The Chemours Company
CC
$12.79
$0.322.57%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.00M | -381.00M | -4.00M | -8.00M | -32.00M |
| Total Depreciation and Amortization | 79.00M | 80.00M | 77.00M | 78.00M | 73.00M |
| Total Amortization of Deferred Charges | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Total Other Non-Cash Items | 1.00M | 93.00M | 27.00M | 11.00M | 61.00M |
| Change in Net Operating Assets | 3.00M | 298.00M | -215.00M | 54.00M | 34.00M |
| Cash from Operations | 146.00M | 93.00M | -112.00M | 138.00M | 139.00M |
| Capital Expenditure | -41.00M | -43.00M | -84.00M | -109.00M | -76.00M |
| Sale of Property, Plant, and Equipment | 6.00M | 1.00M | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -2.00M | 2.00M | 1.00M |
| Cash from Investing | -35.00M | -42.00M | -86.00M | -107.00M | -75.00M |
| Total Debt Issued | 17.00M | 115.00M | 27.00M | 632.00M | 20.00M |
| Total Debt Repaid | -30.00M | -125.00M | -46.00M | -502.00M | -30.00M |
| Issuance of Common Stock | -- | -- | -- | 1.00M | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.00M | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.00M | -13.00M | -37.00M | -36.00M | -38.00M |
| Other Financing Activities | 21.00M | -4.00M | -- | -10.00M | 21.00M |
| Cash from Financing | -5.00M | -27.00M | -57.00M | 85.00M | -27.00M |
| Foreign Exchange rate Adjustments | 6.00M | 15.00M | 6.00M | -19.00M | 10.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.00M | 39.00M | -249.00M | 97.00M | 47.00M |